Stay updated on TH1902 in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the TH1902 in Advanced Solid Tumors Clinical Trial page.

Latest updates to the TH1902 in Advanced Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedThe page revision label updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded study locations in Michigan, Pennsylvania, Texas, and Quebec, and removed corresponding location sections. Also removed the HHS Vulnerability Disclosure link and updated revision labels from v3.3.2 to v3.3.3.SummaryDifference0.5%

- Check54 days agoChange DetectedThe page's revision label updated from v3.2.0 to v3.3.2; no other content on the page appears to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check61 days agoChange DetectedRemoved the global funding/operating-status banner that warned about potential delays, noted NIH guidelines, and directed users to opm.gov for status updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check75 days agoChange DetectedThe Detailed Description now states that enrollment in Part 2 has been paused while the study design is revisited to improve the risk-benefit ratio. The continuation of Part 2 for current beneficiaries will proceed, and Part 3 (dose optimization) and Part 4 (basket expansion) will resume with revised plans.SummaryDifference0.4%

- Check104 days agoChange DetectedAdded government operating-status notice and current version v3.2.0; removed 'Small cell lung carcinoma' and previous version v3.1.0.SummaryDifference2%

Stay in the know with updates to TH1902 in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TH1902 in Advanced Solid Tumors Clinical Trial page.